Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 119419
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.119419
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.119419
Table 2 Therapeutic targets: Inhibition of neutrophil extracellular traps to ameliorate progression of inflammatory bowel disease
| Agent | Target molecule/function | Effect | Disease/animal model | Ref. |
| Cl-amidine | PAD inhibitor | Inhibit colon inflammation; stimulate apoptosis of inflammatory cells in vitro and in vivo | DSS-induced mouse model | Chumanevich et al[66] |
| Butyrate | Suppresses neutrophil migration and NETs production | Ameliorate mucosal inflammation | DSS-induced murine colitis | Li et al[69] |
| Cyclosporine A | Inhibit NETs via the regulating PPP | Reduce ROS-dependent NETs release via downregulating PPP and cellular ROS levels by decreasing G6PD activity directly by activating the P53 protein | DSS-induced colitis mouse model | Xu et al[70] |
| Hydroxychloroquine | Inhibit NET formation | HCQ inhibit the activation of MEK/ERK/ROS signaling pathway | DSS induced colitis | Jiang and Zhang[74] |
| Thymopentin | Inhibit NET formation | Reduced DAI, weight loss and colon shrinkage; decreased MPO, NE, citH3, PAD4, dsDNA | TNBS-induced colitis mouse model | Cao et al[79] |
| PAD4 genetic deficiency | Down-regulate cGAS-STING pathway | Inhibit NET formation, protect the intestinal barrier, alleviate intestinal inflammation | DSS-induced colitis mice | Sun et al[46] |
| CXCR1 and CXCR2 | Promote UC and NET formation through neutrophil chemotaxis and PAD4-mediated pathways | Higher expression of CXCR1/CXCR2 in colon tissues of UC patients | UC; summary data from a genome-wide association study and FinnGen | Xv et al[71] |
| Hydrogen sulfide | Inhibit NET formation | Inhibit the expression of NF-κB and HMGB1; elevate the expression of anti-inflammatory mediator UCHL-1 | TNBS-induced colitis rat model | Török et al[80] |
- Citation: Qi Y, Ma L, Zhang Y, Liu Y, Su M, Cai TT, Wang M, Sun KW. Insights into the pathogenic roles and targeted therapy of neutrophil extracellular traps in inflammatory bowel disease. World J Gastroenterol 2026; 32(17): 119419
- URL: https://www.wjgnet.com/1007-9327/full/v32/i17/119419.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i17.119419